Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
Recent Activity - Last 12 Months
uO Research has been collecting usage data since January 2013. To the best of our ability, this data excludes entries from search engines. Statistics are available at the item, collection and repository level.